High Vista Strategies LLC Chimerix Inc Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.23 - $7.18 $79,558 - $109,222	-15,212 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.75 $90,359 - $133,105	15,212 New	15,212 $94,000
Q1 2021 May 17, 2021	SELL	$4.76 - $11.25 $98,850 - $233,628	-20,767 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.43 - $5.42 $50,463 - $112,557	20,767 New	20,767 $100,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.